149 related articles for article (PubMed ID: 3983219)
1. Tolerance, cross-tolerance, and receptors after chronic nicotine or oxotremorine.
Marks MJ; Collins AC
Pharmacol Biochem Behav; 1985 Feb; 22(2):283-91. PubMed ID: 3983219
[TBL] [Abstract][Full Text] [Related]
2. Species differences in diisopropylfluorophosphate-induced decreases in the number of brain nicotinic receptors.
Van de Kamp JL; Collins AC
Pharmacol Biochem Behav; 1992 May; 42(1):131-41. PubMed ID: 1528936
[TBL] [Abstract][Full Text] [Related]
3. Genetic influences on tolerance development with chronic oxotremorine infusion.
Marks MJ; Romm E; Collins AC
Pharmacol Biochem Behav; 1987 Aug; 27(4):723-32. PubMed ID: 3659096
[TBL] [Abstract][Full Text] [Related]
4. Cross-tolerance between muscarinic agonists: role of muscarinic receptors.
Collins AC; Smolen TN; Smolen A; Medhurst LJ
Pharmacol Biochem Behav; 1987 Jan; 26(1):173-82. PubMed ID: 3562489
[TBL] [Abstract][Full Text] [Related]
5. Changes in sensitivity to nicotine and brain nicotinic receptors following chronic nicotine and corticosterone treatments in mice.
Robinson SF; Grun EU; Pauly JR; Collins AC
Pharmacol Biochem Behav; 1996 Jul; 54(3):587-93. PubMed ID: 8743633
[TBL] [Abstract][Full Text] [Related]
6. Dissociation of decreased numbers of muscarinic receptors from tolerance to DFP.
Smolen TN; Smolen A; Collins AC
Pharmacol Biochem Behav; 1986 Dec; 25(6):1293-301. PubMed ID: 3809233
[TBL] [Abstract][Full Text] [Related]
7. Nicotine-induced tolerance and receptor changes in four mouse strains.
Marks MJ; Romm E; Gaffney DK; Collins AC
J Pharmacol Exp Ther; 1986 Jun; 237(3):809-19. PubMed ID: 3712280
[TBL] [Abstract][Full Text] [Related]
8. Time course study of the effects of chronic nicotine infusion on drug response and brain receptors.
Marks MJ; Stitzel JA; Collins AC
J Pharmacol Exp Ther; 1985 Dec; 235(3):619-28. PubMed ID: 4078726
[TBL] [Abstract][Full Text] [Related]
9. Differential alterations of cholinergic muscarinic receptors during chronic and acute tolerance to organophosphorus insecticides.
Costa LG; Schwab BW; Murphy SD
Biochem Pharmacol; 1982 Nov; 31(21):3407-13. PubMed ID: 7150362
[TBL] [Abstract][Full Text] [Related]
10. Dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains.
Marks MJ; Stitzel JA; Collins AC
J Pharmacol Exp Ther; 1986 Nov; 239(2):358-64. PubMed ID: 3772799
[TBL] [Abstract][Full Text] [Related]
11. Chronic ethanol or nicotine treatment results in partial cross-tolerance between these agents.
Burch JB; de Fiebre CM; Marks MJ; Collins AC
Psychopharmacology (Berl); 1988; 95(4):452-8. PubMed ID: 3145516
[TBL] [Abstract][Full Text] [Related]
12. Influence of kinetics of nicotine administration on tolerance development and receptor levels.
Marks MJ; Stitzel JA; Collins AC
Pharmacol Biochem Behav; 1987 Jul; 27(3):505-12. PubMed ID: 2821553
[TBL] [Abstract][Full Text] [Related]
13. Effect of a single dose of an acetylcholinesterase inhibitor on oxotremorine- and nicotine-induced hypothermia in mice.
Clement JG
Pharmacol Biochem Behav; 1991 Aug; 39(4):929-34. PubMed ID: 1763113
[TBL] [Abstract][Full Text] [Related]
14. Regulation of brain nicotinic receptors by chronic agonist infusion.
Bhat RV; Turner SL; Selvaag SR; Marks MJ; Collins AC
J Neurochem; 1991 Jun; 56(6):1932-9. PubMed ID: 2027007
[TBL] [Abstract][Full Text] [Related]
15. Modulation by nicotine on binding of cerebral muscarinic receptors with muscarinic agonist and antagonist.
Wang H; Cui WY; Liu CH
Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):497-9. PubMed ID: 9863140
[TBL] [Abstract][Full Text] [Related]
16. Selective changes in sensitivity to cholinergic agonists and receptor changes elicited by continuous physostigmine infusion.
Bhat RV; Turner SL; Marks MJ; Collins AC
J Pharmacol Exp Ther; 1990 Oct; 255(1):187-96. PubMed ID: 2213555
[TBL] [Abstract][Full Text] [Related]
17. Genetic influences on acute responses to nicotine and nicotine tolerance in the mouse.
Collins AC; Miner LL; Marks MJ
Pharmacol Biochem Behav; 1988 May; 30(1):269-78. PubMed ID: 3174752
[TBL] [Abstract][Full Text] [Related]
18. The effects of chronic oxotremorine treatment on spatial learning and tolerance development in mice.
Wehner JM; Upchurch M
Pharmacol Biochem Behav; 1989 Feb; 32(2):543-51. PubMed ID: 2727016
[TBL] [Abstract][Full Text] [Related]
19. Affinity ligands and related agents for brain muscarinic and nicotinic cholinergic receptors.
Abood LG; Saraswati M; Lerner-Marmarosh N; Hashmi M
Biochem Pharmacol; 1993 May; 45(10):2143-8. PubMed ID: 8512596
[TBL] [Abstract][Full Text] [Related]
20. Tolerance to and cross tolerance between ethanol and nicotine.
Collins AC; Burch JB; de Fiebre CM; Marks MJ
Pharmacol Biochem Behav; 1988 Feb; 29(2):365-73. PubMed ID: 3362930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
